Chronic Inflammatory Demyelinating Polyneuropathy Treatment Overview

CONDITION AND TREATMENT OVERVIEW Chronic Inflammatory Demyelinating Polyneuropathy

If you have been diagnosed with chronic inflammatory demyelinating polyneuropathy, you may be wondering what comes next? Getting from moment-to-moment each day can be daunting and difficult to manage. If your doctor has recommended infusion therapy to treat your CIDP, then take charge of what comes next, give Infusion for Health a call to discuss your treatment options today. Let us help you stop living moment-to-moment, so you can start living for your future.

What is Chronic Inflammatory Demyelinating Polyneuropathy?

Chronic inflammatory demyelinating polyneuropathy, also known as CIDP, is a rare and progressive neurological disorder. CIDP is closely related to Guillain-Barre syndrome, and it is considered the chronic counterpart of that acute disease. Caused by an autoimmune response, CIDP initiates the body’s own immune system to attack and destroy the protective coverings surrounding the peripheral nerves. This damage causes disruption between signals from the brain to parts of the body; primarily the arms and legs, leading to weakness and loss of sensation.

Symptoms of CIDP include:

• Weakness
• Numbness
• Slow reflexes
• Difficulty swallowing
• Double vision
• Exhaustion

CIDP is more common in older adults. Manifesting first as a lack of coordination, then progressing into a decline of motor functions. If left untreated chronic inflammatory demyelinating polyneuropathy (CIDP) can lead to permanent disability.